Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians

Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians

Abstract Introduction Some patients with rheumatoid arthritis (RA) using tumor necrosis factor inhibitors (TNFi) experience inefficacy or lack of tolerability and hence switch to another TNFi (cycling) or to a therapy with another mode of action (switching). This study examined patient characteristi...

Descripció completa

Dades bibliogràfiques
Autors principals: Emma Sullivan, Jim Kershaw, Stuart Blackburn, Jeannie Choi, Jeffrey R. Curtis, Susan Boklage
Format: Article
Idioma:English
Publicat: Adis, Springer Healthcare 2020-04-01
Col·lecció:Rheumatology and Therapy
Matèries:
Biologic disease-modifying antirheumatic drugs
Cycling
Rheumatoid arthritis
Switching
Tumor necrosis factor inhibitors
Accés en línia:https://doi.org/10.1007/s40744-020-00203-w

Internet

https://doi.org/10.1007/s40744-020-00203-w

Ítems similars